Estimating historical disease burden and the impact of vaccination by influenza type and subtype in the United States, 2016-2020.

Saved in:
Bibliographic Details
Title: Estimating historical disease burden and the impact of vaccination by influenza type and subtype in the United States, 2016-2020.
Authors: Morris SE; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329.; Goldbelt Professional Services, Chesapeake, VA, USA, 23320., Mathis SM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Chung JR; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Flannery B; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., O'Halloran A; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Cummings CN; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Garg S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Lu PJ; Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Santibanez TA; Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Reed C; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Biggerstaff M; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329., Iuliano AD; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA, 30329.
Source: Vaccine: X [Vaccine X] 2025 Oct; Vol. 26. Date of Electronic Publication: 2025 Aug 13.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101748769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-1362 (Electronic) Linking ISSN: 25901362 NLM ISO Abbreviation: Vaccine X Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2590-1362
DOI:10.1016/j.jvacx.2025.100700